EU approves Afinitor for certain breast cancers
Monday, July 30, 2012 - 10:30
in Health & Medicine
GENEVA (AP) -- Swiss drug maker Novartis AG says it has received European approval to market Afinitor for treatment of women with the most common form of advanced breast cancer....